|
參考文獻 1.Rizzetto, M., Canese, M. G., Arico, S., Crivelli, O., Trepo, C., Bonino, F., and Verme, G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut (1977) 18, 997-1003. 2.Rizzetto, M., Canese, M. G., Gerin, J. L., London, W. T., Sly, D. L., and Purcell, R. H. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 141, 590-602. 3.Rizzetto, M., Hoyer, B., Canese, M. G., Shih, J. W., Purcell, R. H., and Gerin, J. L. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 77, 6124-8. 4.Wang, K. S., Choo, Q. L., Weiner, A. J., Ou, J. H., Najarian, R. C., Thayer, R. M., Mullenbach, G. T., Denniston, K. J., Gerin, J. L., and Houghton, M. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 323, 508-14. 5.Farci, P. Delta hepatitis: an update. J Hepatol (2003) 39 Suppl 1, S212-9. 6.Radjef, N., Gordien, E., Ivaniushina, V., Gault, E., Anais, P., Drugan, T., Trinchet, J. C., Roulot, D., Tamby, M., Milinkovitch, M. C., and Deny, P. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol (2004) 78, 2537-44. 7.Taylor, J. M. Hepatitis delta virus. Virology (2006) 344, 71-6. 8.Kuo, M. Y., Goldberg, J., Coates, L., Mason, W., Gerin, J., and Taylor, J. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 62, 1855-61. 9.Jayan, G. C., and Casey, J. L. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J Virol (2002) 76, 12399-404. 10.Jayan, G. C., and Casey, J. L. Increased RNA editing and inhibition of hepatitis delta virus replication by high-level expression of ADAR1 and ADAR2. J Virol (2002) 76, 3819-27. 11.Wong, S. K., and Lazinski, D. W. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A (2002) 99, 15118-23. 12.Tseng, C. H., and Lai, M. M. Hepatitis delta virus RNA replication. Viruses (2009) 1, 818-31. 13.Li, Y. J., Stallcup, M. R., and Lai, M. M. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol (2004) 78, 13325-34. 14.Mu, J. J., Chen, D. S., and Chen, P. J. The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. J Virol (2001) 75, 9087-95. 15.Tseng, C. H., Jeng, K. S., and Lai, M. M. Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis. J Virol (2008) 82, 9409-16. 16.Glenn, J. S., Watson, J. A., Havel, C. M., and White, J. M. Identification of a prenylation site in delta virus large antigen. Science (1992) 256, 1331-3. 17.Kuo, M. Y., Chao, M., and Taylor, J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol (1989) 63, 1945-50. 18.Chen, P. J., Chang, F. L., Wang, C. J., Lin, C. J., Sung, S. Y., and Chen, D. S. Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J Virol (1992) 66, 2853-9. 19.Chang, F. L., Chen, P. J., Tu, S. J., Wang, C. J., and Chen, D. S. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A (1991) 88, 8490-4. 20.Ryu, W. S., Bayer, M., and Taylor, J. Assembly of hepatitis delta virus particles. J Virol (1992) 66, 2310-5. 21.Bonino, F., Heermann, K. H., Rizzetto, M., and Gerlich, W. H. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 58, 945-50. 22.Sureau, C., Guerra, B., and Lanford, R. E. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol (1993) 67, 366-72. 23.Sureau, C., Guerra, B., and Lee, H. The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus. J Virol (1994) 68, 4063-6. 24.Wu, J. C., Chen, P. J., Kuo, M. Y., Lee, S. D., Chen, D. S., and Ting, L. P. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol (1991) 65, 1099-104. 25.Greco-Stewart, V. S., Schissel, E., and Pelchat, M. The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. Virology (2009) 386, 12-5. 26.Modahl, L. E., Macnaughton, T. B., Zhu, N., Johnson, D. L., and Lai, M. M. RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 20, 6030-9. 27.Greco-Stewart, V. S., Miron, P., Abrahem, A., and Pelchat, M. The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome. Virology (2007) 357, 68-78. 28.Chou, H. C., Hsieh, T. Y., Sheu, G. T., and Lai, M. M. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol (1998) 72, 3684-90. 29.Reid, C. E., and Lazinski, D. W. A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc Natl Acad Sci U S A (2000) 97, 424-9. 30.Polson, A. G., Bass, B. L., and Casey, J. L. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature (1996) 380, 454-6. 31.Sureau, C., Fournier-Wirth, C., and Maurel, P. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus. J Virol (2003) 77, 5519-23. 32.Engelke, M., Mills, K., Seitz, S., Simon, P., Gripon, P., Schnolzer, M., and Urban, S. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology (2006) 43, 750-60. 33.Pascarella, S., and Negro, F. Hepatitis D virus: an update. Liver Int (2010) 31, 7-21. 34.Huang, C., Chang, S. C., Yu, I. C., Tsay, Y. G., and Chang, M. F. Large hepatitis delta antigen is a novel clathrin adaptor-like protein. J Virol (2007) 81, 5985-94. 35.Huang, C., Chang, S. C., Yang, H. C., Chien, C. L., and Chang, M. F. Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus. J Virol (2009) 83, 12314-24. 36.Le Gal, F., Gault, E., Ripault, M. P., Serpaggi, J., Trinchet, J. C., Gordien, E., and Deny, P. Eighth major clade for hepatitis delta virus. Emerg Infect Dis (2006) 12, 1447-50. 37.Imazeki, F., Omata, M., and Ohto, M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol (1990) 64, 5594-9. 38.Wu, J. C., Chen, C. M., Sheen, I. J., Lee, S. D., Tzeng, H. M., and Choo, K. B. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology (1995) 22, 1656-60. 39.Ivaniushina, V., Radjef, N., Alexeeva, M., Gault, E., Semenov, S., Salhi, M., Kiselev, O., and Deny, P. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol (2001) 82, 2709-18. 40.Casey, J. L., Brown, T. L., Colan, E. J., Wignall, F. S., and Gerin, J. L. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A (1993) 90, 9016-20. 41.Wu, J. C., Chiang, T. Y., and Sheen, I. J. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol (1998) 79 ( Pt 5), 1105-13. 42.Su, C. W., Huang, Y. H., Huo, T. I., Shih, H. H., Sheen, I. J., Chen, S. W., Lee, P. C., Lee, S. D., and Wu, J. C. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology (2006) 130, 1625-35. 43.Wu, J. C. Functional and clinical significance of hepatitis D virus genotype II infection. Curr Top Microbiol Immunol (2006) 307, 173-86. 44.Niro, G. A., Smedile, A., Andriulli, A., Rizzetto, M., Gerin, J. L., and Casey, J. L. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (1997) 25, 728-34. 45.Rizzetto, M., Purcell, R. H., and Gerin, J. L. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet (1980) 1, 1215-8. 46.Gaeta, G. B., Stroffolini, T., Smedile, A., Niro, G., and Mele, A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology (2007) 46, 1312-3. 47.Smedile, A., Rizzetto, M., and Gerin, J. L. Advances in hepatitis D virus biology and disease. Prog Liver Dis (1994) 12, 157-75. 48.Rizzetto, M., Bonino, F., and Verme, G. Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis. Semin Liver Dis (1988) 8, 350-6. 49.Cross, T. J., Rizzi, P., Horner, M., Jolly, A., Hussain, M. J., Smith, H. M., Vergani, D., and Harrison, P. M. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol (2008) 80, 277-82. 50.Rizzetto, M., Verme, G., Recchia, S., Bonino, F., Farci, P., Arico, S., Calzia, R., Picciotto, A., Colombo, M., and Popper, H. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 98, 437-41. 51.Zachou, K., Yurdaydin, C., Drebber, U., Dalekos, G. N., Erhardt, A., Cakaloglu, Y., Degertekin, H., Gurel, S., Zeuzem, S., Bozkaya, H., Schlaphoff, V., Dienes, H. P., Bock, T. C., Manns, M. P., and Wedemeyer, H. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int (2009) 30, 430-7. 52.Williams, V., Brichler, S., Radjef, N., Lebon, P., Goffard, A., Hober, D., Fagard, R., Kremsdorf, D., Deny, P., and Gordien, E. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol (2009) 90, 2759-67. 53.Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, F., Brechot, C., and Kremsdorf, D. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J Virol (2001) 75, 2684-91. 54.Schaper, M., Rodriguez-Frias, F., Jardi, R., Tabernero, D., Homs, M., Ruiz, G., Quer, J., Esteban, R., and Buti, M. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol (2010) 52, 658-64. 55.Castellares, C., Barreiro, P., Martin-Carbonero, L., Labarga, P., Vispo, M. E., Casado, R., Galindo, L., Garcia-Gasco, P., Garcia-Samaniego, J., and Soriano, V. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome. J Viral Hepat (2008) 15, 165-72. 56.Sheng, W. H., Hung, C. C., Kao, J. H., Chang, S. Y., Chen, M. Y., Hsieh, S. M., Chen, P. J., and Chang, S. C. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis (2007) 44, 988-95. 57.Rizzetto, M. Hepatitis D: thirty years after. J Hepatol (2009) 50, 1043-50. 58.Wedemeyer, H., and Manns, M. P. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol (2010) 7, 31-40. 59.Erhardt, A., Gerlich, W., Starke, C., Wend, U., Donner, A., Sagir, A., Heintges, T., and Haussinger, D. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int (2006) 26, 805-10. 60.Castelnau, C., Le Gal, F., Ripault, M. P., Gordien, E., Martinot-Peignoux, M., Boyer, N., Pham, B. N., Maylin, S., Bedossa, P., Deny, P., Marcellin, P., and Gault, E. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology (2006) 44, 728-35. 61.Niro, G. A., Ciancio, A., Gaeta, G. B., Smedile, A., Marrone, A., Olivero, A., Stanzione, M., David, E., Brancaccio, G., Fontana, R., Perri, F., Andriulli, A., and Rizzetto, M. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology (2006) 44, 713-20. 62.Everson, G. T. Treatment of patients with hepatitis C virus on the waiting list. Liver Transpl (2003) 9, S90-4. 63.Sun, Y., Chang, B., Teng, G., Zhang, W., Zhao, J., Zou, Z., and Li, B. Combination Therapy for Patients Decompensated Liver Cirrhosis with HCV Infection. Hepatogastroenterology 60. 64.Di Martino, V., Thevenot, T., Colin, J. F., Boyer, N., Martinot, M., Degos, F., Coulaud, J. P., Vilde, J. L., Vachon, F., Degott, C., Valla, D., and Marcellin, P. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology (2002) 123, 1812-22. 65.Yurdaydin, C. A multicenter randomised study comparing the efficacy of pegylated interferon‑alfa‑2a plus adevofir dipivoxil vs. pegylated interferon‑alfa‑2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep‑net/international delta hepatitis intervention trial (HID‑IT). Hepatology (2006) 44, 230A. 66.Wedemeyer, H. 72 WEEK DATA OF THE HIDIT-I TRIAL: A MULTICENTER RANDOMISED STUDY COMPARING PEGINTERFERON a-2a PLUS ADEFOVIR VS. PEGINTERFERON a-2a PLUS PLACEBO VS. ADEFOVIR IN CHRONIC DELTA HEPATITIS. J. Hepatol. (2007) 46, S4. 67.Yurdaydin, C., Bozkaya, H., Gurel, S., Tillmann, H. L., Aslan, N., Okcu-Heper, A., Erden, E., Yalcin, K., Iliman, N., Uzunalimoglu, O., Manns, M. P., and Bozdayi, A. M. Famciclovir treatment of chronic delta hepatitis. J Hepatol (2002) 37, 266-71. 68.Wolters, L. M., van Nunen, A. B., Honkoop, P., Vossen, A. C., Niesters, H. G., Zondervan, P. E., and de Man, R. A. Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus. J Viral Hepat (2000) 7, 428-34. 69.Lau, D. T., Doo, E., Park, Y., Kleiner, D. E., Schmid, P., Kuhns, M. C., and Hoofnagle, J. H. Lamivudine for chronic delta hepatitis. Hepatology (1999) 30, 546-9. 70.Yurdaydin, C., Bozkaya, H., Onder, F. O., Senturk, H., Karaaslan, H., Akdogan, M., Cetinkaya, H., Erden, E., Erkan-Esin, O., Yalcin, K., Bozdayi, A. M., Schinazi, R. F., Gerin, J. L., Uzunalimoglu, O., and Ozden, A. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J Viral Hepat (2008) 15, 314-21. 71.Garripoli, A., Di Marco, V., Cozzolongo, R., Costa, C., Smedile, A., Fabiano, A., Bonino, F., Rizzetto, M., Verme, G., Craxi, A., and et al. Ribavirin treatment for chronic hepatitis D: a pilot study. Liver (1994) 14, 154-7. 72.Wedemeyer, H., Yurdaydin, C., Dalekos, G. N., Erhardt, A., Cakaloglu, Y., Degertekin, H., Gurel, S., Zeuzem, S., Zachou, K., Bozkaya, H., Koch, A., Bock, T., Dienes, H. P., and Manns, M. P. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med (2011) 364, 322-31. 73.Sheldon, J., Ramos, B., Toro, C., Rios, P., Martinez-Alarcon, J., Bottecchia, M., Romero, M., Garcia-Samaniego, J., and Soriano, V. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Antivir Ther (2008) 13, 97-102. 74.Jardi, R., Rodriguez, F., Buti, M., Costa, X., Cotrina, M., Galimany, R., Esteban, R., and Guardia, J. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology (2001) 34, 404-10. 75.Komla-Soukha, I., and Sureau, C. A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles. J Virol (2006) 80, 4648-55. 76.Hourioux, C., Sureau, C., Poisson, F., Brand, D., Goudeau, A., and Roingeard, P. Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains. J Gen Virol (1998) 79 ( Pt 5), 1115-9. 77.Kao, J. H., Chen, P. J., Lai, M. Y., and Chen, D. S. Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol (2002) 40, 3047-9. 78.Chang, S. Y., Yang, C. L., Ko, W. S., Liu, W. C., Lin, C. Y., Wu, C. H., Su, Y. C., Chang, S. F., Chen, M. Y., Sheng, W. H., Hung, C. C., and Chang, S. C. Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan. J Clin Microbiol (2011) 49, 1083-9. 79.Huo, T. I., Wu, J. C., Lin, R. Y., Sheng, W. Y., Chang, F. Y., and Lee, S. D. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol (1997) 12, 747-51. 80.Hsu, H. M., Wang, Y. F., Lo, S. H., Sun, H. C., Yip, K. K., Chen, J. S., Chuang, C. H., and Chen, D. S. Hepatitis D virus infection among intravenous drug abusers in Taiwan: analysis of risk factors and liver function tests. J Med Virol (1990) 31, 76-81. 81.Chu, F. Y., Chiang, S. C., Su, F. H., Chang, Y. Y., and Cheng, S. H. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan. J Med Virol (2009) 81, 973-8. 82.Epidemiology of Hepatitis Delta Virus infection in HIV-infected individuals in Taiwan. Retrovirology 9 Suppl 1, P49. 83.Sun, H. Y., Chang, S. Y., Yang, Z. Y., Lu, C. L., Wu, H., Yeh, C. C., Liu, W. C., Hsieh, C. Y., Hung, C. C., and Chang, S. C. Recent hepatitis C virus infections in HIV-infected patients in Taiwan: incidence and risk factors. J Clin Microbiol 50, 781-7. 84.Lin, H. H. Epidemiology of Hepatitis Delta Virus infection in HIV-infected individuals in Taiwan. Retrovirology (2012) 9, Suppl 1. 85.Lee, C. Z., Lin, J. H., Chao, M., McKnight, K., and Lai, M. M. RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 67, 2221-7.
|